ForbesGroupon Cofounder’s Health Startup Hits $2 Billion Valuation With Latest Funding RoundAug 30, 2018CardiologyOncologyMedia CoverageRelated contentA Decade of Discovery: Tempus Supported Almost 1,500 Research Projects in 10 YearsTempus Announces Four Abstracts Accepted for Presentation at the 2024 San Antonio Breast Cancer SymposiumTempus Announces Four Abstracts Accepted For Presentation at the European Society for Medical Oncology Congress 2024